{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:41:00Z","timestamp":1773794460472,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.vaccine.2023.01.010","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T16:03:20Z","timestamp":1673280200000},"page":"1274-1279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anti-varicella-zoster virus antibody titers and seroprotection status from before the first dose of varicella vaccination to before entering elementary school in one region in Japan"],"prefix":"10.1016","volume":"41","author":[{"given":"Takao","family":"Ozaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensei","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.01.010_b0005","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.01.010_b0010","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.vaccine.2016.04.059","article-title":"Development of varicella vaccine in Japan and future prospects","volume":"34","author":"Ozaki","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.010_b0015","unstructured":"Japan Pediatric Society. Vaccination schedule recommended by the Japan Pediatric Society, October 1, 2020. http:\/\/www.jpeds.or.jp\/uploads\/files\/2020%20English%20JPS%20Immunization%20Schedule.pdf."},{"key":"10.1016\/j.vaccine.2023.01.010_b0020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s10156-013-0577-x","article-title":"Varicella vaccination in Japan: necessity of implementing a routine vaccination program","volume":"19","author":"Ozaki","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2023.01.010_b0025","first-page":"462","article-title":"Cumulative vaccination coverage of Japanese children on the national surveys in 2017 and 2018","volume":"22","author":"Sakiyama","year":"2019","journal-title":"JAGP"},{"key":"10.1016\/j.vaccine.2023.01.010_b0030","first-page":"129","article-title":"Varicella\/herpes zoster: epidemiological trends and vaccine","volume":"39","author":"National Institute of Infectious Diseases","year":"2018","journal-title":"IASR"},{"key":"10.1016\/j.vaccine.2023.01.010_b0035","unstructured":"National Institute of Infectious Diseases, IDWR. Varicella (chickenpox) cases reported per sentinel weekly. Comparison with past 10 years weekly report. https:\/\/www.niid.go.jp\/niid\/ja\/10\/2096-weeklygraph\/1648-05varicella.html."},{"key":"10.1016\/j.vaccine.2023.01.010_b0040","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1016\/j.vaccine.2020.09.038","article-title":"Trend in varicella patients 4 years after implementation of universal two-dose varicella vaccination in Japan","volume":"38","author":"Hattori","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.010_b0045","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1016\/j.vaccine.2021.04.009","article-title":"Evaluation of varicella vaccine effectiveness during outbreaks in schools or nurseries by cross-sectional study","volume":"39","author":"Kawamura","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.010_b0050","first-page":"1523","article-title":"Antibody response with routine two-dose varicella vaccination","volume":"121","author":"Ozaki","year":"2017","journal-title":"J Jpn Pediatr Soc"},{"key":"10.1016\/j.vaccine.2023.01.010_b0055","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3181\/00379727-151-39302","article-title":"Detection of antibody to Varicella-Zoster virus by immune adherence hemagglutination","volume":"151","author":"Gershon","year":"1976","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2023.01.010_b0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0264-410X(91)90266-9","article-title":"Antibody assays suitable for assessing immune responses to live varicella vaccine","volume":"9","author":"Provost","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.010_b0065","first-page":"82","article-title":"Evaluation of the immunogenicity of varicella vaccine in children using antibody assay associated with protection","volume":"48","author":"Kasai","year":"2020","journal-title":"Rinsho To Uirusu"},{"key":"10.1016\/j.vaccine.2023.01.010_b0070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00006454-200204000-00014","article-title":"Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection","volume":"21","author":"Li","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.01.010_b0075","unstructured":"Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec 2014; 89 (25): 265\u2013287."},{"key":"10.1016\/j.vaccine.2023.01.010_b0080","unstructured":"World Health Organization. Vaccination schedule for varicella. https:\/\/immunizationdata.who.int\/pages\/schedule-by-disease\/varicella.html?ISO_3_CODE=&TARGETPOP_GENERAL=."},{"key":"10.1016\/j.vaccine.2023.01.010_b0085","unstructured":"Centers for Diseases Control and Prevention. Decline in annual incidence of varicella \u2013 selected states, 1990\u20132001. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5237a2.htm."},{"key":"10.1016\/j.vaccine.2023.01.010_b0090","unstructured":"Centers for Diseases Control and Prevention. Nationally notifiable infectious diseases and conditions, United States: annual tables. https:\/\/wonder.cdc.gov\/nndss\/static\/2019\/annual\/2019-table3.html."},{"key":"10.1016\/j.vaccine.2023.01.010_b0095","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.vaccine.2019.10.065","article-title":"Seeking the optimal schedule for chickenpox vaccination in Canada: Using an agent-based model to explore the impact of dose timing, coverage and waning of immunity on disease outcomes","volume":"38","author":"Rafferty","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.010_b0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.11150\/kansenshogakuzasshi.87.409","article-title":"Immunogenicity of additional varicella vaccination 3\u20135 years after the initial vaccination","volume":"87","author":"Ozaki","year":"2013","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.vaccine.2023.01.010_b0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jim.2015.07.011","article-title":"Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-\u03b3 enzyme-linked immunosorbent assay","volume":"426","author":"Hayashida","year":"2015","journal-title":"J Immunol Methods"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23000105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23000105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:21:11Z","timestamp":1759404071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0264410X23000105"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.01.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-varicella-zoster virus antibody titers and seroprotection status from before the first dose of varicella vaccination to before entering elementary school in one region in Japan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}